John Marcinak

2.3k total citations
52 papers, 1.4k citations indexed

About

John Marcinak is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, John Marcinak has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 19 papers in Infectious Diseases and 13 papers in Pharmacology. Recurrent topics in John Marcinak's work include Liver Disease Diagnosis and Treatment (10 papers), Drug-Induced Hepatotoxicity and Protection (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). John Marcinak is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Drug-Induced Hepatotoxicity and Protection (10 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). John Marcinak collaborates with scholars based in United States, Japan and Spain. John Marcinak's co-authors include Arthur L. Frank, Paul C. Schreckenberger, John P. Quinn, Charlie Cao, Prabhakar Viswanathan, Majid Vakilynejad, Eckhard Leifke, Charles Burant, Benhuai Xie and Heather A. Johnstone and has published in prestigious journals such as The Lancet, Diabetes Care and PEDIATRICS.

In The Last Decade

John Marcinak

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Marcinak United States 19 684 403 351 334 314 52 1.4k
Sandra L. Preston United States 25 519 0.8× 941 2.3× 155 0.4× 289 0.9× 214 0.7× 45 2.4k
Katie E. Barber United States 21 827 1.2× 471 1.2× 252 0.7× 176 0.5× 421 1.3× 89 1.5k
Chun‐Yu Lin Taiwan 24 567 0.8× 417 1.0× 365 1.0× 318 1.0× 55 0.2× 93 1.7k
Sun Young Cho South Korea 25 872 1.3× 445 1.1× 332 0.9× 136 0.4× 252 0.8× 145 2.0k
P. H. P. Groeneveld Netherlands 24 454 0.7× 378 0.9× 184 0.5× 118 0.4× 80 0.3× 54 1.4k
William O’Riordan United States 20 1.1k 1.6× 493 1.2× 190 0.5× 455 1.4× 627 2.0× 38 1.8k
Kayla R. Stover United States 17 341 0.5× 309 0.8× 111 0.3× 206 0.6× 122 0.4× 96 999
André N. Sofair United States 17 1.2k 1.7× 1.1k 2.7× 142 0.4× 112 0.3× 107 0.3× 40 1.8k
James R. Lane United States 21 664 1.0× 372 0.9× 216 0.6× 105 0.3× 63 0.2× 68 1.8k
Jennifer C. van Velkinburgh United States 16 136 0.2× 421 1.0× 422 1.2× 155 0.5× 114 0.4× 34 1.4k

Countries citing papers authored by John Marcinak

Since Specialization
Citations

This map shows the geographic impact of John Marcinak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Marcinak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Marcinak more than expected).

Fields of papers citing papers by John Marcinak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Marcinak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Marcinak. The network helps show where John Marcinak may publish in the future.

Co-authorship network of co-authors of John Marcinak

This figure shows the co-authorship network connecting the top 25 collaborators of John Marcinak. A scholar is included among the top collaborators of John Marcinak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Marcinak. John Marcinak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Serag, Hashem B., Hao T. Duong, Fasiha Kanwal, et al.. (2025). Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct‐Acting Antivirals Versus Interferon. Alimentary Pharmacology & Therapeutics. 61(7). 1226–1237. 1 indexed citations
2.
Martinez, Anthony, et al.. (2023). Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021. Harm Reduction Journal. 20(1). 142–142.
3.
Marquez, Loreta, et al.. (2023). Industry Review of Best Practices for Risk Management of Drug-Induced Liver Injury from Development to Real-World Use. Drug Safety. 47(1). 1–22. 3 indexed citations
4.
Forns, Xavier, Jordan J. Feld, Douglas E. Dylla, et al.. (2021). Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts. Advances in Therapy. 38(6). 3409–3426. 7 indexed citations
5.
6.
Marcinak, John, Melvin Munsaka, Paul B. Watkins, Takashi Ohira, & Neila Smith. (2018). Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience. Drug Safety. 41(6). 625–640. 33 indexed citations
7.
Mayer, Michael D., Sai Nudurupati, Xuejun Peng, & John Marcinak. (2014). Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Normal or Varying Degrees of Impaired Renal Function. Drugs in R&D. 14(4). 273–282. 5 indexed citations
8.
Hoehn, K. Sarah, Robert S. Daum, Daniel Glikman, et al.. (2010). Lemierre-like syndrome caused by community-associated methicillin-resistant Staphylococcus aureus complicated by hemorrhagic pericarditis. Pediatric Critical Care Medicine. 11(3). e32–e35. 14 indexed citations
9.
Englund, Janet A., et al.. (2009). HIV Knowledge and Attitudes toward HIV Testing of South Side Chicago Housing Authority Residents. AIDS Patient Care and STDs. 23(1). 23–28. 17 indexed citations
10.
Adler, Amos, John Marcinak, Amy Knight Johnson, et al.. (2009). Inflammatory pseudotumor of the heart caused by Listeria monocytogenes infection. Journal of Infection. 58(2). 161–163. 18 indexed citations
11.
Lederman, Edith, Roque Miramontes, John J. Openshaw, et al.. (2008). Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: An investigation of potential fomites in the home environment. Vaccine. 27(3). 375–377. 27 indexed citations
12.
Marcinak, John & Arthur L. Frank. (2006). Epidemiology and treatment of community-associated methicillin-resistantStaphylococcus aureusin children. Expert Review of Anti-infective Therapy. 4(1). 91–100. 14 indexed citations
13.
Marcinak, John & Arthur L. Frank. (2003). Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Current Opinion in Infectious Diseases. 16(3). 265–269. 98 indexed citations
14.
Hannon, Patricia, et al.. (2002). CHRONIC VULVOVAGINITIS CAUSED BY ANTIBIOTIC-RESISTANT SHIGELLA FLEXNERI IN A PREPUBERTAL CHILD. The Pediatric Infectious Disease Journal. 21(2). 170–172. 16 indexed citations
15.
Frank, Arthur L., et al.. (2002). Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. The Pediatric Infectious Disease Journal. 21(6). 530–534. 221 indexed citations
16.
Frank, Arthur L., et al.. (1999). Increase in Community‐Acquired Methicillin‐ResistantStaphylococcus aureusin Children. Clinical Infectious Diseases. 29(4). 935–936. 80 indexed citations
17.
Marcinak, John. (1993). Comparison of the Safety and Immunogenicity of Acellular (BIKEN) and Whole-Cell Pertussis Vaccines in 15- to 20-Month-Old Children. Archives of Pediatrics and Adolescent Medicine. 147(3). 290–290. 17 indexed citations
18.
19.
Johnstone, Heather A. & John Marcinak. (1990). Candidiasis in the Breastfeeding Mother and Infant. Journal of Obstetric, Gynecologic & Neonatal Nursing. 19(2). 171–173. 19 indexed citations
20.
Marcinak, John. (1988). Evaluation of children with fever ??? 104??F in an emergency department. Pediatric Emergency Care. 4(2). 92–96. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra L. Preston Breakdown of academic impact, for papers by Katie E. Barber Breakdown of academic impact, for papers by Chun‐Yu Lin Breakdown of academic impact, for papers by Sun Young Cho Breakdown of academic impact, for papers by P. H. P. Groeneveld Breakdown of academic impact, for papers by William O’Riordan Breakdown of academic impact, for papers by Kayla R. Stover Breakdown of academic impact, for papers by André N. Sofair Breakdown of academic impact, for papers by James R. Lane Breakdown of academic impact, for papers by Jennifer C. van Velkinburgh
Rankless by CCL
2026